AHA urged the House Energy and Commerce Committee to consider including in its draft legislation to address drug shortages legislative proposals that would support drug manufacturers and protect the supply chain for essential medications without limiting patient access to 340B drugs. 
 
鈥淭he AHA shares the committee鈥檚 concern about ensuring an adequate drug supply. Our member hospitals and health systems rely on drug therapies to care for their patients,鈥 the association wrote. 鈥淚n many cases, access to these critical drugs is in peril, jeopardizing patient health. Hospitals and health systems are most concerned about preserving consistent supply of and access to source generics and other generics, which drug manufacturers may believe lack sufficient business incentive to maintain. While the AHA believes shoring up the drug supply chain is of great importance, accomplishing this goal should not come at the cost of patient care. Reducing access to the 340B Drug Pricing Program would directly impact hospitals鈥 ability to offer a wide range of health care services to some of the nation鈥檚 most vulnerable populations.鈥 

Related News Articles

Headline
Senate Health, Education, Labor, and Pensions Committee Chairman Bill Cassidy, M.D., R-La., today released a report detailing findings from an investigation鈥
Headline
The AHA April 18 filed friend-of-the-court briefs in three cases in support of Louisiana's 340B contract pharmacy law that prohibits drug companies from鈥
Headline
A Minnesota state court April 15 dismissed a lawsuit filed by PhRMA challenging the state鈥檚 law protecting 340B pricing for contract pharmacy arrangements. The鈥
Headline
The White House April 15 released an executive order directing federal agencies to undertake a broad range of tasks aimed at reducing the costs of prescription鈥
Headline
The Department of Health and Human Services said its decision to prevent drug companies from implementing a 340B rebate model 鈥渨as within its statutory鈥
Headline
The AHA this week filed a number of friend-of-the-court briefs in cases before the U.S. District Court for the District of Columbia, urging the court to uphold鈥